Jane Street Group, LLC Protalix Bio Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $616 Billion
  • Q3 2025

A detailed history of Jane Street Group, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 36,500 shares of PLX stock, worth $67,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,500
Holding current value
$67,890
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$1.88 - $2.69 $339,719 - $486,088
180,702 Added 159.05%
294,318 $753,000
Q4 2024

Feb 14, 2025
BUY
$0.99 - $1.92 $66,987 - $129,914
67,664 Added 147.25%
113,616 $218,000
Q3 2024

Nov 14, 2024
SELL
$0.9 - $1.17 $219,876 - $285,839
-244,307 Reduced 84.17%
45,952 $46,000
Q2 2024

Aug 14, 2024
BUY
$1.1 - $1.32 $287,471 - $344,966
261,338 Added 903.63%
290,259 $339,000
Q1 2024

May 15, 2024
BUY
$1.22 - $1.82 $117 - $174
96 Added 0.33%
28,921 $36,000
Q4 2023

Feb 14, 2024
BUY
$1.34 - $1.85 $38,625 - $53,326
28,825 New
28,825 $51,000
Q2 2023

Aug 14, 2023
BUY
$2.0 - $3.36 $472,834 - $794,361
236,417 Added 596.03%
276,082 $552,000
Q1 2023

May 15, 2023
SELL
$1.37 - $2.16 $71,998 - $113,516
-52,554 Reduced 56.99%
39,665 $83,000
Q4 2022

Feb 14, 2023
BUY
$1.0 - $1.37 $13,743 - $18,827
13,743 Added 17.51%
92,219 $126,000
Q3 2022

Nov 14, 2022
SELL
$1.03 - $1.24 $5,232 - $6,299
-5,080 Reduced 6.08%
78,476 $82,000
Q2 2022

Aug 16, 2022
SELL
$1.02 - $1.56 $62,885 - $96,177
-61,652 Reduced 42.46%
83,556 $91,000
Q1 2022

May 17, 2022
BUY
$0.81 - $1.17 $48,235 - $69,673
59,550 Added 69.52%
145,208 $154,000
Q4 2021

Feb 15, 2022
BUY
$0.81 - $1.33 $36,214 - $59,462
44,709 Added 109.18%
85,658 $71,000
Q3 2021

Nov 16, 2021
BUY
$1.31 - $1.87 $12,162 - $17,361
9,284 Added 29.32%
40,949 $54,000
Q2 2021

Aug 16, 2021
SELL
$1.86 - $6.22 $30,993 - $103,643
-16,663 Reduced 34.48%
31,665 $60,000
Q1 2021

May 18, 2021
BUY
$3.58 - $6.45 $93,473 - $168,409
26,110 Added 117.52%
48,328 $215,000
Q4 2020

Feb 17, 2021
BUY
$3.15 - $3.98 $23,804 - $30,076
7,557 Added 51.54%
22,218 $81,000
Q3 2020

Nov 17, 2020
SELL
$3.37 - $3.93 $435,269 - $507,598
-129,160 Reduced 89.81%
14,661 $57,000
Q2 2020

Aug 17, 2020
BUY
$2.19 - $4.5 $204,697 - $420,610
93,469 Added 185.63%
143,821 $542,000
Q1 2020

May 15, 2020
BUY
$2.1 - $4.61 $36,808 - $80,804
17,528 Added 53.4%
50,352 $124,000
Q4 2019

Feb 14, 2020
BUY
$1.8 - $3.28 $59,083 - $107,662
32,824 New
32,824 $105,000

Others Institutions Holding PLX

# of Institutions
82
Shares Held
10.6M
Call Options Held
23.6K
Put Options Held
95.4K
View Full List

About Protalix BioTherapeutics, Inc.

PLX Quotes by TradingView
  • Ticker PLX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,753,400
  • Market Cap $92.5M
  • Description
  • Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...
More about PLX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email